Nu Skin officer awarded performance stock units

Nu Skin Enterprises' Chief Product Officer Steven Keith Hatchett reported stock awards tied to performance-based restricted stock units.

Rhea-AI Filing Summary

Nu Skin Enterprises' Chief Product Officer Steven Keith Hatchett reported stock awards tied to performance-based restricted stock units. On February 10, 2026, performance criteria were met for prior RSU grants, resulting in acquisitions of 8,952 and 43,124 shares of Class A Common Stock at $0.00 per share.

After these awards, Hatchett directly held a total of 219,641 Class A shares. The transactions are coded as grants or other acquisitions rather than open-market purchases.

Insider Trade Summary

Grant/Award: 52,076 shares

Grant/Award 2 txns

Insider Hatchett Steven Keith

Role Chief Product Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	8,952	$0.00	$0.00
Grant/Award	Class A Common Stock	43,124	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 219,641 shares (Direct)

Footnotes (2)

1. F1. On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.
2. F2. On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nu Skin (NUS) report for Steven Keith Hatchett?

Nu Skin reported that Chief Product Officer Steven Keith Hatchett acquired performance-based stock awards. On February 10, 2026, he received 8,952 and 43,124 Class A shares at $0.00 per share when prior restricted stock unit performance conditions were satisfied, increasing his direct ownership.

How many Nu Skin (NUS) shares does Steven Hatchett own after this Form 4?

After the reported Form 4 transactions, Steven Hatchett directly owns 219,641 Nu Skin Class A Common shares. This reflects the addition of 8,952 and 43,124 shares that became eligible for vesting when performance criteria on earlier restricted stock unit grants were met on February 10, 2026.

Were Steven Hatchett’s Nu Skin (NUS) transactions open-market buys or awards?

The transactions were awards, not open-market purchases. Both entries use transaction code A, described as a grant, award, or other acquisition, with a price of $0.00 per share, triggered when performance-based restricted stock unit conditions were achieved on February 10, 2026.

What performance conditions affected Steven Hatchett’s Nu Skin (NUS) stock awards?

The awards came from restricted stock units granted in 2024 and 2025 that depended on Nu Skin meeting specified performance criteria. On February 10, 2026, those performance targets were met, causing 8,952 and 43,124 underlying shares to become eligible for vesting and be reported.

Is Steven Hatchett a major shareholder or officer at Nu Skin (NUS)?

Steven Hatchett is an officer at Nu Skin, serving as Chief Product Officer, according to the filing. He is not listed as a director or 10% owner, but he reports beneficial ownership of 219,641 Class A Common shares after the February 10, 2026 performance-based stock awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 06:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hatchett Steven Keith

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UT 84601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/10/2026		A		8,952(1)	A	$0.00	176,517	D
Class A Common Stock	02/10/2026		A		43,124(2)	A	$0.00	219,641	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

2. On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

	/s/ Gregory Belliston as Attorney-in-Fact for Steven Hatchett	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.